GL
₹2,515.10
+17.10(+0.68%)
GLAXO₹2,515.10+0.68%
Group Companies
Foreign Flows
sector level — not this stockHealthcare sector+₹2,114 Crnet foreign buying
2026-09-01 to 2026-09-15This is the flow into the whole Healthcare sector, not into GLAXO. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.
Supply Chain
suppliers and customers in the graphMacro Sensitivity
rates, currency, commoditiesRevenue by Segment
Business Group
Geographic Exposure
revenue, imports, currencyScenario analysis
stated assumptions, shown workingsGLAXO exposure summary
GlaxoSmithKline Pharmaceuticals Limited reports a single business segment, Pharmaceuticals. GlaxoSmithKline Pharmaceuticals Limited is a constituent of 5 indices, with its largest weights in S&P BSE 200 (0.06%), S&P BSE 500 (0.06%), NIFTY 500 (0.05%). 16 exchange-traded funds hold the stock.
| Index memberships | 5 |
|---|---|
| ETFs holding | 16 |